Wentsworth B. Kennedy

Learn More
About 10 years ago results of the National Board of Medical Examiners (NBME) "Minitest," comprised of samples of questions from NBME Part I and Part II tests, indicated that the change in performance in the total basic science examinations would be minimal between the second and fourth years of medical school. By inserting samples of Part I basic science(More)
The I(1)-imidazoline receptor is a novel target for drug development for hypertension and insulin resistance, major disorders associated with type 2 diabetes. In the present study, we examined the effects of a novel imidazoline agonist S43126, on phosphorylation of protein kinase B (PKB/Akt) and extracellular signal-regulated kinase (ERK1/2) in PC12 cells.(More)
1. Centrally acting imidazoline antihypertensive agents clonidine and moxonidine also act peripherally to contract blood vessels. While these agents act at both I1-imidazoline and alpha 2 adrenergic receptors centrally, the receptor types by which they mediate contraction require further definition. We therefore characterized the receptor subtype by which(More)
  • 1